Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.16%, near the low end of its 5-year range (0.00%–2.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 0.56%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.56%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
0.16%
DEBT TO ASSETS RATIO AVG 10Y
7.72%
DEBT TO ASSETS RATIO AVG 15Y
6.56%
DEBT TO ASSETS RATIO AVG 20Y
4.98%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 589 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Enveric Biosciences, Inc.
Market Cap
$6.58M
Debt to Assets Ratio
0.00%
TTM Avg
0.56%
3Y Avg
0.00%
5Y Avg
0.16%
Market Cap
$6.53M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.76M
Debt to Assets Ratio
0.54%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.91M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.91M
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.05M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.58M | 0.00% | 0.56% | 0.00% | 0.16% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.53M | 0.07% | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.76M | 0.54% | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.83M | 0.00% | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $6.91M | 0.05% | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.91M | 0.11% | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.21M | 0.28% | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.13M | 0.39% | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.05M | 0.02% | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.07M | 0.05% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
10.21
Interest Coverage
-82777.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 2.81% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.10% |
| 2023-03-31 | 0.23% |
| 2022-12-31 | 0.33% |
| 2022-09-30 | 0.29% |
| 2022-06-30 | 0.42% |
| 2022-03-31 | 0.47% |
| 2021-12-31 | 0.66% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.63% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 27.44% |
| 2020-06-30 | 26.54% |
| 2020-03-31 | 29.68% |
| 2019-12-31 | 19.52% |
| 2019-09-30 | 16.63% |
| 2019-06-30 | 17.01% |
| 2019-03-31 | 17.00% |
| 2018-12-31 | 17.57% |
| 2018-09-30 | 10.59% |
| 2018-06-30 | 10.82% |
| 2018-03-31 | 12.42% |
| 2017-12-31 | 13.76% |
| 2017-09-30 | 14.84% |
| 2017-06-30 | 15.00% |
| 2017-03-31 | 13.35% |
| 2016-12-31 | 12.73% |
| 2016-09-30 | 28.08% |
| 2016-06-30 | 45.61% |
| 2016-03-31 | 51.28% |
| 2015-09-30 | 24.76% |
| 2015-06-30 | 47.91% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 7.49% |
| 2013-12-31 | 44.76% |
| 2013-09-30 | 581.28% |
| 2013-06-30 | 376.11% |
| 2013-03-31 | 371.82% |
| 2012-12-31 | 142.86% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.60% |
| 2007-09-30 | 1.46% |
| 2007-06-30 | 3.07% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 2.09% |
| 2006-09-30 | 4.54% |
| 2006-06-30 | 5.68% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 1.16% |
| 2005-09-30 | 3.41% |
| 2005-06-30 | 5.84% |
| 2005-03-31 | 3.17% |
| 2004-12-31 | 4.53% |
| 2004-09-30 | 7.38% |
| 2004-06-30 | 8.27% |
| 2004-03-31 | 8.95% |
| 2003-12-31 | 8.98% |
| 2003-09-30 | 8.49% |
| 2003-06-30 | 11.84% |
| 2003-03-31 | 6.99% |
| 2002-12-31 | 6.44% |
| 2002-09-30 | 6.27% |
| 2002-06-30 | 6.23% |
